14–17 October 2027
IFEMA Madrid
Scientific Submissions
Find peer-review timelines, structured formatting requirements, and primary session tracks
The GCNR 2027 Scientific Programme Committee invites clinical researchers, neuroscientists, and biomedical engineers from around the globe to submit their original abstracts for oral and poster presentation. Accepted submissions are peer-reviewed by our world-class advisory board and published in the GSNR Archives of Neurological Restoration.
Submission Portal Closes April 15 2027: The peer review process for GCNR 2027 will then commence. The scientific committee evaluates 450+ submissions under double-blind protocols. Authors will be notified of their acceptance.
Abstract Submission Opens
November 1, 2026
Abstract Submission Deadline
April 15, 2027
Notification of Abstract Acceptance
June 1, 2027
Harnessing central and peripheral immune cells to drive recovery. Therapeutic target-driven microglia modulation, cytokine traps, and anti-inflammatory CSF systems.
Molecular and structural mechanisms of axon guidance, myelin regeneration, and cell-based scaffolding. Olfactory ensheathing glia and stem cell bio-scaffolds.
Primary results, regulatory pathways, ethics, and multi-centre validation strategies for regenerative neurological therapies and stem cell scaffolding.
Flexible electrodes, organic polymers, brain-machine interfaces, and cytokine-gated biofeedback stimulators are designed to bypass central spinal lesions.
To maintain strict double-blind review, all uploaded manuscripts must adhere exactly to the rules outlined below. Submissions failing to comply are returned without committee assessment.
Language: All abstracts must be submitted and presented in clear, professional English.
Word Limit: The body of the abstract must not exceed 350 words (excluding title, authors, and institutional affiliations).
Structure: Abstract bodies must follow a strict structural sequence
Formatting: Abstracts must be pure text. No images, charts, references, or footnotes are permitted in the submission portal.
Conflict of Interest: The submitting author must provide a complete Conflict of Interest (COI) disclosure during upload.
Anonymity: To preserve double-blind integrity, do not include any author names, institutions, or identifiers in the abstract body.
Presenter Limit: A registered presenter can present a maximum of two accepted abstracts at GCNR 2027.
Congress Faculty Profile
PhD, MSc
Professor of Neurobiology & Neuroimmunology
Harvard Medical School
United States Faculty
Academic Biography & Scope
Prof. Clara Sterling is a pioneer in microglia-mediated synaptic pruning and target-driven neuroimmunotherapy. Over the past twenty years, her research group has decoded how glial cells guide axonal pathfinding and synaptic stability. Her keynote lecture at GCNR 2027 will address therapeutic microglia modulation as a tool for synaptic rebuilding in progressive degenerative diseases.